Common Issues in Prenatal Care: Fetal Growth Restriction.

Fetal growth restriction (FGR) is defined as an ultrasound (US)-determined estimated fetal weight or abdominal circumference less than the 10th percentile according to a population level reference curve. FGR affects up to 10% of pregnancies. Fetuses with FGR are at increased risk of intrauterine mortality and, postnatally, neonatal intraventricular hemorrhage, necrotizing enterocolitis, respiratory distress, hypoglycemia, and suboptimal neurologic, behavioral, and cognitive development. In early-onset FGR (ie, less than 32 weeks' gestation), a detailed US examination is recommended. When FGR is accompanied by polyhydramnios and/or fetal anomalies, genetic testing should be obtained, including chromosomal microarray analysis. The timing of delivery strategy should be based on the severity of growth restriction and findings on fetal tests of well-being (eg, nonstress testing, umbilical artery Doppler velocimetry). No routine prevention strategies are recommended. However, it has been shown that daily low-dose aspirin (ie, 81 mg/day) reduces the risk of FGR when taken by patients with a high risk of preeclampsia.
(Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.)